Higher Semaglutide Dose Demonstrates Superior Efficacy in Obesity, T2D
Use of semaglutide 7.2 mg vs 2.4 mg is associated with superior outcomes in reduction of body weight, waist circumference, and glycated hemoglobin (HbA1c) among individuals with obesity, including those with type 2 diabetes, according to study findings published in The Lancet Diabetes & Endocrinology. Although semaglutide 2.4 mg is approved for weight management among adults with obesity […]